Abrams michael s - direct investment history in Bond laboratories inc

Filed on 2013-01-28 by Abrams Michael S SEC CIK 1497702 Form 4/a

Accession 0001415889-13-000131.txt Sec File: edgar/data/1497702/0001415889-13-000131-index.htm

2013-01-16 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc bought 500000 shares at $0.10 remaining shares owned 500000

Stock Options Bond Laboratories Inc Bnlb.Ob exercise price 0.10 has valueitem expiration due date 2018-01-16 underlying security shares 500000 underlying security title Common Stock

f2 the reporting person acquired the stock options pursuant to the issuer's 2010 plan.
f3 stock options vest ratably over a three-year period, beginning on january 16, 2014.


Filed on 2013-01-28 by Abrams Michael S SEC CIK 1497702 Form 4/a

Accession 0001415889-13-000131.txt Sec File: edgar/data/1497702/0001415889-13-000131-index.htm

2013-01-03 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc remaining shares owned 100000

Stock Options Bond Laboratories Inc Bnlb.Ob exercise date 2012-04-13 exercise price 0.09 has valueitem expiration due date 2017-04-13 underlying security shares 100000 underlying security title Common Stock


Filed on 2013-01-28 by Abrams Michael S SEC CIK 1497702 Form 4/a

Accession 0001415889-13-000131.txt Sec File: edgar/data/1497702/0001415889-13-000131-index.htm

2013-01-03 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc bought 2675000 shares remaining shares owned 3420000

Common Stock Bond Laboratories Inc Bnlb.Ob Transaction code: A Grant, award, or other acquisition

f1 the reporting person acquired the shares of common stock pursuant to the issuer's 2010 equity incentive plan ("2010 plan"). the shares are restricted, and therefore subject to forfeiture until they vest on january 16, 2016. the form 4 originally filed on january 3, 2013 erroneously indicated that a portion of the shares were acquired on such date in a privately negotiated transaction rather than pursuant to the 2010 plan.


Filed on 2013-01-03 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-13-000018.txt Sec File: edgar/data/1497702/0001415889-13-000018-index.htm

2012-12-28 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc remaining shares owned 100000

Stock Options Bond Laboratories Inc Bnlb.Ob exercise date 2012-04-13 exercise price 0.09 has valueitem expiration due date 2017-04-13 underlying security shares 100000 underlying security title Common Stock


Filed on 2013-01-03 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-13-000018.txt Sec File: edgar/data/1497702/0001415889-13-000018-index.htm

2012-12-28 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc bought 1050565 shares remaining shares owned 1795565

Common Stock Bond Laboratories Inc Bnlb.Ob Transaction code: P Open market or private purchase of securities

f1 the reporting person acquired the shares of issuer's common stock for aggregate consideration of $12,500 in a privately negotiated transaction.


Filed on 2012-10-18 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-12-001505.txt Sec File: edgar/data/1497702/0001415889-12-001505-index.htm

2012-08-08 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc remaining shares owned 100000

Stock Options Bond Laboratories Inc Bnlb.Ob exercise date 2012-05-09 exercise price 0.09 has valueitem expiration due date 2017-04-13 underlying security shares 100000 underlying security title Common Stock


Filed on 2012-10-18 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-12-001505.txt Sec File: edgar/data/1497702/0001415889-12-001505-index.htm

2012-08-08 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc bought 120000 shares at $0.045 remaining shares owned 745000

Common Stock Bond Laboratories Inc Bnlb.Ob Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 mr. abrams acquired the shares in a privately negotiated transaction in connection with the settlement of litigation.


Filed on 2012-05-10 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-12-000668.txt Sec File: edgar/data/1497702/0001415889-12-000668-index.htm

2012-05-09 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc bought 100000 shares at $0.09 remaining shares owned 100000

Stock Options Bond Laboratories Inc Bnlb.Ob exercise date 2012-05-09 exercise price 0.09 has valueitem expiration due date 2017-04-13 underlying security shares 100000 underlying security title Common Stock


Filed on 2012-05-10 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-12-000668.txt Sec File: edgar/data/1497702/0001415889-12-000668-index.htm

2012-04-01 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc remaining shares owned 0

Warrants Bond Laboratories Inc Bnlb.Ob exercise date 2009-08-20 exercise price 0.50 has valueitem expiration due date 2014-08-20 underlying security shares 375000 underlying security title Common Stock


Filed on 2012-05-10 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-12-000668.txt Sec File: edgar/data/1497702/0001415889-12-000668-index.htm

2012-04-01 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc remaining shares owned 0

Warrants Bond Laboratories Inc Bnlb.Ob exercise date 2009-08-20 exercise price 0.35 has valueitem expiration due date 2014-08-20 underlying security shares 375000 underlying security title Common Stock


Filed on 2011-03-30 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-11-000173.txt Sec File: edgar/data/1497702/0001415889-11-000173-index.htm

2010-12-31 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc sold 375000 shares at $0.50 remaining shares owned 0

Warrants Bond Laboratories Inc Bnlb.Ob exercise date 2009-08-20 exercise price 0.50 has valueitem expiration due date 2014-08-20 underlying security shares 375000 underlying security title Common Stock

f3 warrants disposed of in exchange for 625,000 shares of common stock. the consideration for the exchange was, in addition to the issuance of the 625,000 shares of common stock, the provision of services provided by to the company by mr. abrams in his capacity as the company's interim chief financial officer.


Filed on 2011-03-30 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-11-000173.txt Sec File: edgar/data/1497702/0001415889-11-000173-index.htm

2010-12-31 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc sold 375000 shares at $0.35 remaining shares owned 0

Warrants Bond Laboratories Inc Bnlb.Ob exercise date 2009-08-20 exercise price 0.35 has valueitem expiration due date 2014-08-20 underlying security shares 375000 underlying security title Common Stock

f3 warrants disposed of in exchange for 625,000 shares of common stock. the consideration for the exchange was, in addition to the issuance of the 625,000 shares of common stock, the provision of services provided by to the company by mr. abrams in his capacity as the company's interim chief financial officer.


Filed on 2011-03-30 by Abrams Michael S SEC CIK 1497702 Form 4

Accession 0001415889-11-000173.txt Sec File: edgar/data/1497702/0001415889-11-000173-index.htm

2010-12-31 Abrams Michael S (CIK 1497702) through Direct (Chief Financial Officer)

Invested in Bond Laboratories Inc bought 625000 shares remaining shares owned 625000

Common Stock Bond Laboratories Inc Bnlb.Ob Transaction code: J Other acquisition or disposition (transaction described in footnotes)

f1 shares were issued in consideration for the exchange of warrants to purchase 750,000 shares of the company's common stock held by mr. abrams, as well as in consideration for services provided to the company by mr. abrams in his capacity as the company's interim chief financial officer.
f2 the number of shares of common stock issued is based on a one-for-one exchange of common stock for the warrants exercisable at $0.35 per share, and one share of common stock for each one and one half warrants exercisable at $0.50 per share.